Watch Demo

Costa Rica Anti-Infective Industry Outlook 2024 - 2028

See how Costa Rica Anti-Infective performed compared to key markets such as Italy, Spain and Croatia.

Key Market Indicators

Costa Rica's anti-infective medicine sales are projected to climb to approximately $39 million by 2028, up from around $38 million in 2023. This marks a modest annual growth rate of 0.3%. Since 2012, the Costa Rican market has seen a yearly increase of 0.9%. As of 2023, Costa Rica ranked 14th globally, with Iceland surpassing it at a similar sales figure. Leading the rankings were Spain, Croatia, and Australia, occupying the second, third, and fourth positions, respectively. On the import front, Costa Rican antibiotics are expected to decrease to roughly $1.75 million by 2028, down from about $1.91 million in 2023, reflecting an average annual decline of 1.5%. Since 1999, the country's demand for antibiotics has diminished by approximately 2.4% each year. In terms of exports, Costa Rica saw a significant drop in antibiotics, totaling just $14,100 in 2018, compared to $48,580 in 2017—a staggering 71% decrease. However, since 2000, the nation's supply of antibiotics has grown by an average of 29.2% annually.

Marketing Banner

Costa Rica Anti-Infective Market Data and Forecasts

How much will Costa Rica Anti-Infective Market grow to 2028?

Forecast: Import of Antibiotics to Costa Rica
Forecast: Import of Erythromycin to Costa Rica
Forecast: Import of Resorcinol to Costa Rica
More in Anti-Infective Industry for 2028